These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


342 related items for PubMed ID: 6186100

  • 1. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza].
    Shvartsman IaS, Tsybul'skaia NV, Ispolatova AV.
    Usp Sovrem Biol; 1982; 94(3):446-60. PubMed ID: 6186100
    [No Abstract] [Full Text] [Related]

  • 2. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA, Peradze TV.
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract] [Full Text] [Related]

  • 3. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis].
    Mukhina LP, Bichurina MA, Rozaeva NR.
    Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508
    [No Abstract] [Full Text] [Related]

  • 4. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R, Lee MS, Walker RE, Stoddard J, Mendelman PM.
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [Abstract] [Full Text] [Related]

  • 5. [Unresolved problems in the specific prevention of influenza].
    Fridman EA, Peradze TV.
    Tr Inst Im Pastera; 1982 Dec; 59():6-12. PubMed ID: 7187568
    [No Abstract] [Full Text] [Related]

  • 6. Secretory immune response after nasal vaccination with live attenuated influenza viruses.
    Crifö S, Vella S, Filiaci F, Resta S, Rocchi G.
    Rhinology; 1980 Jun; 18(2):87-92. PubMed ID: 7403787
    [Abstract] [Full Text] [Related]

  • 7. [Characteristics of immunity in influenza].
    Zilişteanu E, Creţescu L, Maţepiuc.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1975 Jun; 20(3):137-46. PubMed ID: 128102
    [Abstract] [Full Text] [Related]

  • 8. [Course of antibodies in men after vaccination with the inactivated influenca vaccine Alorbat (author's transl)].
    Pressler K, Schenk KD.
    Med Klin; 1978 Sep 22; 73(38):1321-6. PubMed ID: 703655
    [No Abstract] [Full Text] [Related]

  • 9. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C, Megas F, Piercy J.
    Virus Res; 2004 Jul 22; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract] [Full Text] [Related]

  • 10. [Problems of specific cellular immunity against influenza].
    Shvartsman IaS, Ispolatova AV, Tsybul'skaia NV.
    Usp Sovrem Biol; 1979 Jul 22; 88(1):77-92. PubMed ID: 388905
    [No Abstract] [Full Text] [Related]

  • 11. The system of population protection against influenza.
    Shadrin AS, Karpukhin GI, Gararinova VM, Ivanova AS, Erophejeva MK, Efremov BV, Ignatjeva GS, Kustikova YuG, Maksakova VL, Turjeva AV.
    Z Erkr Atmungsorgane; 1985 Jul 22; 165(2):163-70. PubMed ID: 4082659
    [Abstract] [Full Text] [Related]

  • 12. [Problems of specific secretory antiviral immunity].
    Shvartsman IaS.
    Usp Sovrem Biol; 1976 Jul 22; 81(3):429-44. PubMed ID: 788388
    [No Abstract] [Full Text] [Related]

  • 13. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE.
    Vaccine; 2008 Sep 08; 26(38):4940-6. PubMed ID: 18662737
    [Abstract] [Full Text] [Related]

  • 14. Influenza vaccines: T-cell responses deserve more attention.
    Schotsaert M, Saelens X, Leroux-Roels G.
    Expert Rev Vaccines; 2012 Aug 08; 11(8):949-62. PubMed ID: 23002976
    [Abstract] [Full Text] [Related]

  • 15. Influenza vaccination for terminally ill cancer patients receiving palliative care: a preliminary report.
    Sasson M, Mandelboim M, Shvartzman P.
    J Pain Symptom Manage; 2011 Feb 08; 41(2):485-90. PubMed ID: 21145200
    [Abstract] [Full Text] [Related]

  • 16. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa.
    Brokstad KA, Eriksson JC, Cox RJ, Tynning T, Olofsson J, Jonsson R, Davidsson A.
    J Infect Dis; 2002 Apr 01; 185(7):878-84. PubMed ID: 11920311
    [Abstract] [Full Text] [Related]

  • 17. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 May 22; 58(19):521-4. PubMed ID: 19478718
    [Abstract] [Full Text] [Related]

  • 18. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E, Engelhard D, Levy R, Schlezinger M, Morag A, Zakay-Rones Z.
    Vaccine; 2004 Jun 30; 22(20):2566-77. PubMed ID: 15193382
    [Abstract] [Full Text] [Related]

  • 19. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A, Tůmová B.
    Tr Inst Im Pastera; 1982 Jun 30; 59():23-8. PubMed ID: 6764986
    [No Abstract] [Full Text] [Related]

  • 20. [Immunologic reactions following influenza virus vaccination].
    Süss J, Schmidt S, Groh A, Vogt KH, Schmidt J.
    Z Gesamte Hyg; 1985 Mar 30; 31(3):149-53. PubMed ID: 4013413
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.